Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 01:39:44 - browse：96

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： The explosion of genetic testing requires a new approach

leisure time

knowledge

explore

WSS

Hospital price transparency does save money, advocate argues

FDA's naming rule on biosimilars has undermined competition

UnitedHealth’s board chair also owns a personal investment firm

Why health workers in Gaza are injured or die at high rates

Patient advocates debate FDA's accelerated approval process

Donor acceptance rates hint at racial, gender bias in heart transplants: study

focus

Wikipedia

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Will Ozempic

United colonoscopy coverage change 'may cost lives,' doctors say

Pharmacists can make shortage drugs, but at what cost?

Malaria cases in Florida and Texas: Here’s what you need to know

Senate committee scrutinizes Medicare Advantage brokers

Cancer drug shortages should be causing more outrage

FDA gives detailed accounting of AI

23andMe had bad news about my health. I wish a person had delivered it

CEOs share strategies for surviving biotech slump

entertainment

Pharmacists can make shortage drugs, but at what cost?

FDA warns J&J's Abiomed: We will regulate your software

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Researchers explore possible ties between long Covid, menopause

Medicare reduced heart disease by changing how it pays doctors

Oprah kicked off a national conversation on obesity. Let's have it

leisure time

knowledge

explore

https://cbu01.alicdn.com/img/ibank/2011/059/901/424109950_1634758566.220x220xz.jpg